130 related articles for article (PubMed ID: 17474797)
41. Number of negative points: a novel method for predicting radiosensitivity in head and neck tumor cell lines.
Farnebo L; Jerhammar F; Vainikka L; Grénman R; Norberg-Spaak L; Roberg K
Oncol Rep; 2008 Aug; 20(2):453-61. PubMed ID: 18636211
[TBL] [Abstract][Full Text] [Related]
42. No evidence for association of the TP53 12139 and the BAX-248 polymorphisms with endemic pemphigus foliaceus (fogo selvagem).
Köhler KF; Petzl-Erler ML
Int J Immunogenet; 2006 Apr; 33(2):141-4. PubMed ID: 16611260
[TBL] [Abstract][Full Text] [Related]
43. TP53 codon 72 polymorphism in susceptibility, overall survival, and adjuvant therapy response of gliomas.
Lima-Ramos V; Pacheco-Figueiredo L; Costa S; Pardal F; Silva A; Amorim J; Lopes JM; Reis RM
Cancer Genet Cytogenet; 2008 Jan; 180(1):14-9. PubMed ID: 18068527
[TBL] [Abstract][Full Text] [Related]
44. p53 codon 72 polymorphisms in human papillomavirus-negative and human papillomavirus-positive squamous cell carcinomas of the oropharynx.
Perrone F; Mariani L; Pastore E; Orsenigo M; Suardi S; Marcomini B; DaRiva L; Licitra L; Carbone A; Pierotti MA; Pilotti S
Cancer; 2007 Jun; 109(12):2461-5. PubMed ID: 17492690
[TBL] [Abstract][Full Text] [Related]
45. Polymorphisms in BRCA2 resulting in aberrant codon-usage and their analysis on familial breast cancer risk.
Yang R; Chen B; Hemminki K; Wappenschmidt B; Engel C; Sutter C; Ditsch N; Weber BH; Niederacher D; Arnold N; Meindl A; Bartram CR; Schmutzler RK; Burwinkel B
Breast Cancer Res Treat; 2009 Nov; 118(2):407-13. PubMed ID: 19229607
[TBL] [Abstract][Full Text] [Related]
46. p53 Arg72Pro polymorphism predicts survival outcome in lung cancer patients in Indian population.
Sreeja L; Syamala V; Raveendran PB; Santhi S; Madhavan J; Ankathil R
Cancer Invest; 2008 Feb; 26(1):41-6. PubMed ID: 18181044
[TBL] [Abstract][Full Text] [Related]
47. Association of p53 polymorphism with ICSI/IVF failure and recurrent pregnancy loss.
Firouzabadi RD; Ghasemi N; Rozbahani MA; Tabibnejad N
Aust N Z J Obstet Gynaecol; 2009 Apr; 49(2):216-9. PubMed ID: 19432615
[TBL] [Abstract][Full Text] [Related]
48. Genetic polymorphisms in TP53, nonsteroidal anti-inflammatory drugs and the risk of colorectal cancer: evidence for gene-environment interaction?
Tan XL; Nieters A; Hoffmeister M; Beckmann L; Brenner H; Chang-Claude J
Pharmacogenet Genomics; 2007 Aug; 17(8):639-45. PubMed ID: 17622940
[TBL] [Abstract][Full Text] [Related]
49. PDCD1, CTLA-4 and p53 gene polymorphism and susceptibility to gestational trophoblastic diseases.
Dehaghani AS; Kashef MA; Ghaemenia M; Sarraf Z; Khaghanzadeh N; Fattahi MJ; Ghaderi A
J Reprod Med; 2009 Jan; 54(1):25-31. PubMed ID: 19263877
[TBL] [Abstract][Full Text] [Related]
50. TP53 and TP53-related genes associated with protection from apoptosis in the radioadaptive response.
Okazaki R; Ootsuyama A; Norimura T
Radiat Res; 2007 Jan; 167(1):51-7. PubMed ID: 17214514
[TBL] [Abstract][Full Text] [Related]
51. Cytokine gene polymorphisms in Colombian patients with systemic lupus erythematosus.
Guarnizo-Zuccardi P; Lopez Y; Giraldo M; Garcia N; Rodriguez L; Ramirez L; Uribe O; Garcia L; Vasquez G
Tissue Antigens; 2007 Nov; 70(5):376-82. PubMed ID: 17711410
[TBL] [Abstract][Full Text] [Related]
52. [Correlation analysis between clinical phenotypes of keloids and polymorphism of p53 gene codon 72].
Liu Y; Gao J; Liu X; Lu F; Liu H
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Dec; 22(12):1433-6. PubMed ID: 19137883
[TBL] [Abstract][Full Text] [Related]
53. Overview of radiosensitivity of human tumor cells to low-dose-rate irradiation.
Williams JR; Zhang Y; Zhou H; Gridley DS; Koch CJ; Slater JM; Little JB
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):909-17. PubMed ID: 19014780
[TBL] [Abstract][Full Text] [Related]
54. COX2 and p53 risk-alleles coexist in COPD.
Arif E; Vibhuti A; Deepak D; Singh B; Siddiqui MS; Pasha MA
Clin Chim Acta; 2008 Nov; 397(1-2):48-50. PubMed ID: 18692035
[TBL] [Abstract][Full Text] [Related]
55. TP53 codon 72 polymorphism and type 2 diabetes: a case-control study in South Indian population.
Punja HK; Nanjappa DP; Babu N; Kalladka K; Shanti Priya Dias B; Chakraborty G; Rao SM; Chakraborty A
Mol Biol Rep; 2021 Jun; 48(6):5093-5097. PubMed ID: 34181170
[TBL] [Abstract][Full Text] [Related]
56. p53 codon 72 polymorphism and HPV status in lung cancer.
Buyru N; Altinisik J; Isin M; Dalay N
Med Sci Monit; 2008 Sep; 14(9):CR493-7. PubMed ID: 18758421
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of the polymorphisms in the exons 2 to 4 of the TP53 in cervical carcinoma patients from a Brazilian population.
Fernandes TA; Lima GL; De Souza FC; Fernandes JV; Meissner RV
Cell Mol Biol (Noisy-le-grand); 2008 Jun; 54 Suppl():OL1025-31. PubMed ID: 18954551
[TBL] [Abstract][Full Text] [Related]
58. TP53 codon 72 single nucleotide polymorphism in chronic lymphocytic leukemia.
Bilous NI; Abramenko IV; Chumak AA; Dyagil IS; Martіna ZV
Exp Oncol; 2014 Dec; 36(4):258-61. PubMed ID: 25537220
[TBL] [Abstract][Full Text] [Related]
59. Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes.
Andreassen CN; Alsner J; Overgaard M; Overgaard J
Radiother Oncol; 2003 Nov; 69(2):127-35. PubMed ID: 14643949
[TBL] [Abstract][Full Text] [Related]
60. Does skin fibroblast radiosensitivity predict squamous cancer cell radiosensitivity of the same individual?
Haikonen J; Rantanen V; Pekkola K; Kulmala J; Grénman R
Int J Cancer; 2003 Mar; 103(6):784-8. PubMed ID: 12516099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
